TRAVERE THERAPEUTICS INC's ticker is TVTX and the CUSIP is 89422G107. A total of 174 filers reported holding TRAVERE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,002,560 | -89.4% | 224,000 | -69.4% | 0.00% | -88.0% |
Q1 2022 | $18,838,000 | +18.8% | 731,000 | +43.1% | 0.02% | +47.1% |
Q4 2021 | $15,861,000 | +42.8% | 511,000 | +11.6% | 0.02% | +30.8% |
Q3 2021 | $11,107,000 | +112.7% | 458,000 | +27.9% | 0.01% | +116.7% |
Q2 2021 | $5,223,000 | – | 358,000 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Finepoint Capital LP | 875,221 | $19,683,720 | 7.52% |
Deep Track Capital, LP | 6,147,268 | $138,252,057 | 5.68% |
Kynam Capital Management, LP | 1,563,595 | $35,165,252 | 4.54% |
GREAT POINT PARTNERS LLC | 1,003,000 | $22,557,470 | 4.43% |
ARMISTICE CAPITAL, LLC | 7,148,000 | $160,758,520 | 2.32% |
HighVista Strategies LLC | 121,834 | $2,740,047 | 2.23% |
MPM BioImpact LLC | 313,642 | $7,053,809 | 1.83% |
Sofinnova Investments, Inc. | 1,263,721 | $28,421,085 | 1.82% |
Octagon Capital Advisors LP | 495,000 | $11,132,550 | 1.60% |
SECTORAL ASSET MANAGEMENT INC | 358,613 | $8,065,206 | 1.55% |